Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PainTx is a topical cannabidiol cream developed by Good Pharmaceutical Development Company for localized pain relief. The product contains highly purified cannabidiol isolate with stated 99% cannabidiol and 0% THC, formulated as a cream for topical application and positioned for chronic pain, inflammation, neuropathic pain, and muscle pain. Its proposed mechanism is modulation of the endocannabinoid system, including cannabinoid receptor 1 and cannabinoid receptor 2 signaling, to reduce pain and inflammatory responses. Based on the provided company and product context, PainTx appears to be a commercially marketed CBD topical product rather than a conventionally phased prescription drug program, although it has been described as clinically tested in a small randomized study.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PainTx.